J-
We (AMSI) make clinical decision support products to be used retrospectively (how did we do), concurrently (how is my patient doing today), and prospectively (how is my patient expected to do tomorrow) for high risk & high cost patients. Out products embed our "science" internally so that the clinicians, case managers, or quaility managers can objectively know their patients' risks of death, complications, need for active treatment, etc for cardiovascular patients, med-surg patients, and Intensive Care Unit patients etc in REAL time with an extremely high level of statistical and clinical validity.
Our databases contain data on hundreds of thousands of patients, are growing at a rather fast clip, and contain highly clinical data such as a patient's daily vital signs and physiologic variables.
This particular market segment is expected (at least by myself!) to be an explosive growth area over the next 2-10 years. Right now the field is populated with very small companies, with not much competition in the "concurrent & prospective" arena, but I expect this to change over the next year or so (based on competitor announcements) with the larger companinies (HBOC etc) to gain interest as the winning companies become more clearly defined.
I, of course, am confident that APACHE Medical Systems, Inc. will be one of the winners, with a good likelyhood of being THE winner. But then again, I am a employee of the company!
Scott Armstrong
APACHE Medical Systems, Inc.
NASDAQ: AMSI |
